Synapse - Genitourinary Oncology Service

Search Within

Genitourinary Oncology Service

Results (5696)

Somatic copy number abnormalities (SCNAs) and mutations in PI3K/AKT pathway as prognostic factors for overall survival (OS) in platinum-treated locally advanced or metastatic urothelial tumors

Meeting Abstract

Bellmunt, J.; Werner, L.; Leow, J. J.; Mullane, S. A.; Riester, M.; Van Hummelen, P.; Rosenberg, J. E.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Q-TWiST analysis of patients with metastatic renal cell carcinoma (mRCC) randomized to pazopanib (PAZ) or sunitinib (SUN)

Meeting Abstract

Beaumont, J. L.; Diaz, J.; Deen, K. C.; McCann, L.; Powles, T.; Hackshaw, M. D.; Motzer, R. J.; Cella, D.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

A first-in-human study of pegylated recombinant human IL-10 (AM0010), daily administered for four months in selected advanced solid tumors

Meeting Abstract

Bauer, T. M.; Papadopoulos, K. P.; Autio, K. A.; Ott, P. A.; Whiteside, M.; Oft, M.; Infante, J. R.; Hod, F. S.; Wolchok, J. D.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Preliminary product parameter and safety results from NeuACT, a phase 2 randomized, open-label trial of DN24-02 in patients with surgically resected HER2+urothelial cancer at high risk for recurrence

Meeting Abstract

Bajorin, D. F.; Gomella, L. G.; Sharma, P.; Plimack, E. R.; O'Donnell, P. H.; Hoffman-Censits, J. H.; Flaig, T. W.; Quinn, D. I.; Campogan, D.; Haynes, H.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

A two-part phase 2 randomized study of dalantercept and axitinib versus placebo plus axitinib in advanced renal cell carcinoma: Results from the part 1 dose escalation cohorts

Meeting Abstract

Atkins, M. B.; Voss, M. H.; Plimack, E. R.; Rini, B. I.; Alter, R.; Dawson, N. A.; Beck, J. T.; Bhatt, R. S.; Pappas, K. M.; Wilson, D.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Primary, secondary, and quality-of-life endpoint results from PREVAIL, a phase 3 study of enzalutamide in men with metastatic castration resistant prostate cancer (mCRPC)

Meeting Abstract

Armstrong, A. J.; Tombal, B.; Sternberg, C. N.; Higano, C. S.; Rathkopf, D. E.; Loriot, Y.; Saad, F.; Joshua, A. M.; de Bono, J. S.; Venner, P. M.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients (pts) with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Amin, A.; Plimack, E. R.; Infante, J. R.; Ernstoff, M. S.; Rini, B. I.; McDermott, D. F.; Knox, J. J.; Pal, S. K.; Voss, M. H.; Sharma, P.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Stomatitis incidence and its relationship with efficacy: A meta-analysis of everolimus clinical studies

Meeting Abstract

Rugo, H. S.; Yao, J. C.; Pavel, M.; Ravaud, A.; Franz, D. N.; Taran, T.; Gallo, J.; Rouyrre, N.; Anak, O.; Motzer, R. J.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Reply to C. Anderson and J.M. Buatti

Journal Article

Ward, M. M.; Ullrich, F.; Rushton, G.; Bajorin, D. F.; Jacobson, G. M.; Lynch, C. F.
Journal of Oncology Practice (2014)

Fulltext@MSK | Save

Oncogenic RAF mutants that signal as functional dimers are resistant to current RAF inhibitors but sensitive to a novel inhibitor of RAF dimer kinase activity

Meeting Abstract

Yao, Z.; Torres, M.; Wei, M.; Hanrahan, A.; Abdel-Wahab, O.; Solit, D.; Luo, L. S.; Poulikakos, P.; Rosen, N.
Cancer Research (2014)

Fulltext@MSK | Save